Works matching IS 15228517 AND DT 2019 AND VI 21 AND IP 1

Results: 19

Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 14, doi. 10.1093/neuonc/noy170
By:
- Chiocca, E Antonio;
- Nassiri, Farshad;
- Wang, Justin;
- Peruzzi, Pierpaolo;
- Zadeh, Gelareh
Publication type:
Article
Immunotherapy in CNS cancers: the role of immune cell trafficking.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 37, doi. 10.1093/neuonc/noy084
By:
- Ratnam, Nivedita M;
- Gilbert, Mark R;
- Giles, Amber J
Publication type:
Article
Highlights from the Literature.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 11, doi. 10.1093/neuonc/noy197
By:
- Soffietti, Riccardio;
- Chamberlain, Marc;
- Purow, Benjamin;
- Bhat, Krishna;
- Wright, Karen
Publication type:
Article
Forthcoming Meetings.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 142, doi. 10.1093/neuonc/noy196
Publication type:
Article
Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 137, doi. 10.1093/neuonc/noy153
By:
- Belting, Mattias;
- Bång-Rudenstam, Anna;
- Englund, Elisabet;
- Pietsch, Torsten
Publication type:
Article
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 47, doi. 10.1093/neuonc/noy123
By:
- Cho, Hee Jin;
- Zhao, Junfei;
- Jung, Sang Won;
- Ladewig, Erik;
- Kong, Doo-Sik;
- Suh, Yeon-Lim;
- Lee, Yeri;
- Kim, Donggeon;
- Ahn, Sun Hee;
- Bordyuh, Mykola;
- Kang, Hyun Ju;
- Sa, Jason K;
- Seo, Yun Jee;
- Kim, Sung Tae;
- Lim, Do Hoon;
- Dho, Yun-Sik;
- Lee, Jung-Il;
- Seol, Ho Jun;
- Choi, Jung Won;
- Park, Woong-Yang
Publication type:
Article
Differences in molecular profiles of glioblastomas according to location.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 4, doi. 10.1093/neuonc/noy172
By:
- Horbinski, Craig
Publication type:
Article
CNS inflammatory disorder after concurrent radiotherapy-temozolomide and nivolumab in a glioblastoma patient.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 139, doi. 10.1093/neuonc/noy168
By:
- Stefano, Anna Luisa Di;
- Savatovsky, Julien;
- Feuvret, Loic;
- Villa, Chiara;
- Reina, Vincent;
- Pha, Micheline;
- Houillier, Caroline;
- Berzero, Giulia;
- Idbaih, Ahmed;
- Psimaras, Dimitri
Publication type:
Article
Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 83, doi. 10.1093/neuonc/noy145
By:
- Lieberman, Nicole A P;
- DeGolier, Kole;
- Kovar, Heather M;
- Davis, Amira;
- Hoglund, Virginia;
- Stevens, Jeffrey;
- Winter, Conrad;
- Deutsch, Gail;
- Furlan, Scott N;
- Vitanza, Nicholas A;
- Leary, Sarah E S;
- Crane, Courtney A
Publication type:
Article
Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 59, doi. 10.1093/neuonc/noy120
By:
- Park, Ae Kyung;
- Kim, Pora;
- Ballester, Leomar Y;
- Esquenazi, Yoshua;
- Zhao, Zhongming
Publication type:
Article
Sex-specific gene and pathway modeling of inherited glioma risk.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 71, doi. 10.1093/neuonc/noy135
By:
- Ostrom, Quinn T;
- Coleman, Warren;
- Huang, William;
- Rubin, Joshua B;
- Lathia, Justin D;
- Berens, Michael E;
- Speyer, Gil;
- Liao, Peter;
- Wrensch, Margaret R;
- Eckel-Passow, Jeanette E;
- Armstrong, Georgina;
- Rice, Terri;
- Wiencke, John K;
- McCoy, Lucie S;
- Hansen, Helen M;
- Amos, Christopher I;
- Bernstein, Jonine L;
- Claus, Elizabeth B;
- Houlston, Richard S;
- Il'yasova, Dora
Publication type:
Article
Reviewer Lists for Neuro-Oncology.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 8, doi. 10.1093/neuonc/noy198
Publication type:
Article
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 26, doi. 10.1093/neuonc/noy137
By:
- Huang, Raymond Y;
- Bi, Wenya Linda;
- Weller, Michael;
- Kaley, Thomas;
- Blakeley, Jaishri;
- Dunn, Ian;
- Galanis, Evanthia;
- Preusser, Matthias;
- McDermott, Michael;
- Rogers, Leland;
- Raizer, Jeffrey;
- Schiff, David;
- Soffietti, Riccardo;
- Tonn, Jörg-Christian;
- Vogelbaum, Michael;
- Weber, Damien;
- Reardon, David A;
- Wen, Patrick Y
Publication type:
Article
A platform for efficient early evaluation of biomarker-associated therapies in newly diagnosed IDH wild-type, MGMT unmethylated glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 6, doi. 10.1093/neuonc/noy190
By:
- Colman, Howard
Publication type:
Article
Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 115, doi. 10.1093/neuonc/noy093
By:
- Dasgupta, Archya;
- Gupta, Tejpal;
- Pungavkar, Sona;
- Shirsat, Neelam;
- Epari, Sridhar;
- Chinnaswamy, Girish;
- Mahajan, Abhishek;
- Janu, Amit;
- Moiyadi, Aliasgar;
- Kannan, Sadhana;
- Krishnatry, Rahul;
- Sastri, Goda Jayant;
- Jalali, Rakesh
Publication type:
Article
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 106, doi. 10.1093/neuonc/noy091
By:
- Lassman, Andrew B;
- Bent, Martin J van den;
- Gan, Hui K;
- Reardon, David A;
- Kumthekar, Priya;
- Butowski, Nicholas;
- Lwin, Zarnie;
- Mikkelsen, Tom;
- Nabors, Louis B;
- Papadopoulos, Kyriakos P;
- Penas-Prado, Marta;
- Simes, John;
- Wheeler, Helen;
- Walbert, Tobias;
- Scott, Andrew M;
- Gomez, Erica;
- Lee, Ho-Jin;
- Roberts-Rapp, Lisa;
- Xiong, Hao;
- Ansell, Peter J
Publication type:
Article
Neurologic disorders in 4858 survivors of central nervous system tumors in childhood—an Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 125, doi. 10.1093/neuonc/noy094
By:
- Kenborg, Line;
- Winther, Jeanette Falck;
- Linnet, Karen Markussen;
- Krøyer, Anja;
- Albieri, Vanna;
- Holmqvist, Anna Sällfors;
- Tryggvadottir, Laufey;
- Madanat-Harjuoja, Laura Maria;
- Stovall, Marilyn;
- Hasle, Henrik;
- Olsen, Jørgen H;
- group, ALiCCS study
Publication type:
Article
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 95, doi. 10.1093/neuonc/noy161
By:
- Wick, Wolfgang;
- Dettmer, Susan;
- Berberich, Anne;
- Kessler, Tobias;
- Karapanagiotou-Schenkel, Irini;
- Wick, Antje;
- Winkler, Frank;
- Pfaff, Elke;
- Brors, Benedikt;
- Debus, Jürgen;
- Unterberg, Andreas;
- Bendszus, Martin;
- Herold-Mende, Christel;
- Eisenmenger, Andreas;
- Deimling, Andreas von;
- Jones, David T W;
- Pfister, Stefan M;
- Sahm, Felix;
- Platten, Michael
Publication type:
Article
The lomustine crisis: awareness and impact of the 1500% price hike.
Published in:
Neuro-Oncology, 2019, v. 21, n. 1, p. 1, doi. 10.1093/neuonc/noy189
By:
- Taylor, Jennie W;
- Armstrong, Terri;
- Kim, Albert H;
- Venere, Monica;
- Acquaye, Alvina;
- Schrag, Deborah;
- Wen, Patrick Y
Publication type:
Article